Rexgene Biotech Co., Ltd.'s Net Worth
$5.61 Million
Who is Rexgene Biotech Co., Ltd.?
Rexgene Biotech Co., Ltd. has an estimated net worth of $5.61 Million. This is based on reported shares in REXAHN PHARMACEUTICALS, INC..
SEC CIK
Rexgene Biotech Co., Ltd.'s CIK is 0001316425
Past Insider Trading and Trends
2007 was Rexgene Biotech Co., Ltd.'s most active year for acquiring shares with 2 total transactions. Rexgene Biotech Co., Ltd.'s most active month to acquire stocks was the month of November. 2007 saw Rexgene Biotech Co., Ltd. paying a total of $1,000,000.40 for 857,143 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
REXAHN PHARMACEUTICALS, INC. (OCUP) Snapshot price: $1.2001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.91% | 714.29K |
$1.40 | $1,000,000.40 | 5.51M |
Dec 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||